Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q1 Mar/2026 1.02 -0.650 -1.03 May/11
FY2025Q4 Dec/2025 -0.3 -0.270 -2.04 Mar/16
FY2025Q3 Sep/2025 1.94 -0.280 -3.08 Nov/10
FY2025Q2 Jun/2025 -1.0 -0.270 -2.52 Aug/11
Mar/2025 -1.03 -0.260 May/12




Eps Cambiamento Data
AbbVie USD 3.65 1 2026-06
Agenus USD 1.02 1.32 2026-03
Amgen USD 6.29 1.14 2026-06
AstraZeneca USD 2.63 0.05 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Celldex Therapeutics USD -0.94 0.24 2026-06
CSL USD 5.07 3 2025-12
Eli Lilly USD 8.38 0.17 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
GlaxoSmithKline GBP 0.51 0.08 2026-06
Glaxosmithkline GBP 0.62 0.41 2026-03
Incyte USD 3.09 1.28 2026-06
Intrexon USD -0.1 0.03 2024-06
J&J USD 2.9 0.2 2026-06
Jiangsu Hengrui CNY 0.34 0.05 2026-03
Karyopharm Therapeutics USD -1.02 1.2 2026-03
MacroGenics USD -0.58 0.36 2026-03
Merck EUR -0.54 2.65 2026-06
Merck USD -0.13 1.15 2026-06
Northwest Biotherapeutics USD -0.01 0 2026-03
Novartis USD 2.41 0.42 2026-06
Novavax USD 0.13 0.59 2025-12
Pfizer USD 0.77 0.02 2026-06
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Sangamo BioSciences USD -0.18 0.1 2024-06
Veracyte USD 0.54 0.02 2026-06